Search Results - Beale, Keola

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Evaluation of In Vivo P-Glycoprotein Phenotyping Probes: A Need for Validation

    Evaluation of In Vivo P-Glycoprotein Phenotyping Probes: A Need for Validation by Ma, Joseph D., Tsunoda, Shirley M., Bertino, Joseph S., Trivedi, Meghana, Beale, Keola K., Nafziger, Anne N.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants

    Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants by Beale, Keola K.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants

    Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants by Beale, Keola K

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer

    ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colore... by Reid, Tony R., Abrouk, Nacer, Caroen, Scott, Oronsky, Bryan, Stirn, Meaghan, Larson, Christopher, Beale, Keola, Knox, Susan J., Fisher, George

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study

    Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” stu... by Reid, Tony, Carney, Jennifer, Beale, Keola, Clayton, Chan, Nguyen, Huy, Cho-Phan, Cheryl, Stirn, Meaghan, Ning, Shoucheng, Knox, Susan, Oronsky, Bryan, Scicinski, Jan, Caroen, Scott, Parker, Christopher, Fanger, Gary R., Fisher, George

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors

    Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors by King, Peter J, Lee, Deborah J, Reinke, Ryan A, Victoria, Joseph G, Beale, Keola, Robinson, W.Edward

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1

    Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1 by Beale, Keola K., Robinson, W.Edward

    Published in Antiviral research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: